Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials

被引：0
|
作者：
Ibrahim Elmakaty
Ruba Abdo
Ahmed Elsabagh
Abdelrahman Elsayed
Mohammed Imad Malki
机构：
[1] QU Health,College of Medicine
[2] Qatar University,Pathology Unit, Department of Basic Medical Sciences, College of Medicine
[3] QU Health,undefined
[4] Qatar University,undefined
来源：
Cancer Cell International | / 23卷
关键词：
PD-1/PD-L1 inhibitors; Immune checkpoint inhibitors; Overall survival; Progression-free survival; Pathological complete response; Adverse events; Efficacy; Safety; Systematic review; Network meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The effects and safety of PD-1/PD-L1 inhibitors on head and neck cancer: A systematic review and meta-analysis
    Wang, Bi-Cheng
    Cao, Ru-Bo
    Li, Pin-Dong
    Fu, Chen
    CANCER MEDICINE, 2019, 8 (13): : 5969 - 5978
  • [22] Efficacy of PD-1/PD-L1 inhibitors in patients with advanced gastroesophageal cancer: An updated meta-analysis based on randomized controlled trials
    Gu, Lihu
    Huang, Tongmin
    Qiu, Shinan
    Hong, Jiaze
    Fu, Rongrong
    Ni, Chaoxiong
    Dai, Senjie
    Chen, Ping
    He, Ning
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [23] Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
    Shen, Xian
    Zhao, Bin
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
  • [24] Efficacy and Safety of PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer: A Network Analysis of Randomized Controlled Trials
    Li, Xiang
    Yan, Shi
    Yang, Jichun
    Wang, Yaqi
    Lv, Chao
    Li, Shaolei
    Zhao, Jun
    Yang, Yue
    Zhuo, Minglei
    Wu, Nan
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [25] PD-1/PD-L1 immune checkpoint inhibitors in the treatment of unresectable locally advanced or metastatic triple negative breast cancer: a meta-analysis on their efficacy and safety
    Zuxiu Wang
    Peimeng You
    Zhanglei Yang
    Hanxi Xiao
    Xinrong Tang
    Yongping Pan
    Xuhuan Li
    Feng Gao
    BMC Cancer, 24 (1)
  • [26] Efficacy and safety of PD-1/PD-L1 inhibitors in patients with Merkel Cell Carcinoma: a systematic review and Meta-analysis
    Francisco Cezar Aquino de Moraes
    Michele Kreuz
    Isabella Christina Amaral de Lara
    Artur de Oliveira Macena Lôbo
    Rommel Mario Rodríguez Burbano
    BMC Cancer, 24 (1)
  • [27] Effectiveness and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a systematic review and meta-analysis
    Han, Songfei
    Guo, Cuishan
    Song, Zixuan
    Ouyang, Ling
    Wang, Yizi
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [28] PD-1/PD-L1 Inhibitors Monotherapy for the Treatment of Endometrial Cancer: Meta-Analysis and Systematic Review
    Dai, Yun
    Muaibati, Munawaer
    Xie, Weiming
    Abasi, Abuduyilimu
    Li, Kexin
    Tong, Qing
    Zhang, Tao
    Meng, Yifan
    Zhuang, Liang
    Huang, Xiaoyuan
    CANCER INVESTIGATION, 2022, 40 (03) : 293 - 309
  • [29] Cardiovascular Toxicity With PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis
    Liu, Surui
    Gao, Wei
    Ning, Yan
    Zou, Xiaomeng
    Zhang, Weike
    Zeng, Liangjie
    Liu, Jie
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [30] EFFICACY AND SAFETY OF PD-1/PD-L1 INHIBITORS USED IN THE TREATMENT OF PATIENTS WITH ADVANCED AND METASTATIC MELANOMA - A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Oguzhan, G.
    Caliskan, Z.
    Kockaya, G.
    Kurnaz, M.
    Calli, C.
    Erturk, S. M.
    VALUE IN HEALTH, 2020, 23 : S50 - S50
12345